Heart Test Laboratories (HSCS)

• Market cap: $3.57M
• 1 day: 7.84%
• 5 days: -7.04%
• 1 month: 10.00%
• 3 months: -4.90%
• 6 months: 3.77%
• Year to date: -11.76%
• 1 year: -67.33%
• 5 years: -98.06%
• 10 years: -98.06%
• Sector: Healthcare
• Industry: Medical Devices

About: HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.

Employees: 12

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

1.29% less ownership

Funds ownership: 1.43% [Q3] → 0.14% (-1.29%) [Q4]

50% less funds holding

Funds holding: 6 [Q3] → 3 (-3) [Q4]

91% less capital invested

Capital invested by funds: $61.9K [Q3] → $5.4K (-$56.5K) [Q4]

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $14 324% upside
• Avg. target: $14 324% upside
• High target: $14 324% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Ascendiant Capital Lucas Ward 25% 1-year accuracy 3 / 12 met price target

324% upside $14

Buy Maintained

18 Mar 2025